MYC and MCL1, which are frequently co-overexpressed in breast cancer stem cells (BCSC) of TNBC, act as enhancers of mitochondrial OXPHOS and synergistically upregulate HIF-1α expression. This evidence concerns the gene MYC and breast carcinoma.